Publications by authors named "Murray Feingold"

Whole-exome sequencing (WES) is increasingly being utilized to diagnose individuals with undiagnosed disorders. Developmental delay and short stature are common clinical indications for WES. We performed WES in three families, using proband-parent trios and two additional affected siblings.

View Article and Find Full Text PDF

The SATB2-associated syndrome (SAS) was recently proposed as a clinically recognizable syndrome that results from deleterious alterations of the SATB2 gene in humans. Although interstitial deletions at 2q33 encompassing SATB2, either alone or contiguously with other genes, have been reported before, there is limited literature regarding intragenic mutations of this gene and the resulting phenotype. We describe five patients in whom whole exome sequencing identified five unique de novo mutations in the SATB2 gene (one splice site, one frameshift, and three nonsense mutations).

View Article and Find Full Text PDF

Background: Floating-Harbor syndrome (FHS) is a rare condition characterized by short stature, delays in expressive language, and a distinctive facial appearance. Recently, heterozygous truncating mutations in SRCAP were determined to be disease-causing. With the availability of a DNA based confirmatory test, we set forth to define the clinical features of this syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • - Meier-Gorlin syndrome (MGS) is a rare genetic disorder marked by traits like primordial dwarfism, microtia, and issues with patella development, linked to mutations in specific genes involved in DNA replication.
  • - A recent study of 45 MGS patients found that growth is notably slow during pregnancy and the first year, but by adulthood, individuals average a height that is significantly below normal (about -4.5 standard deviations).
  • - Growth hormone therapy has been mostly ineffective, but some individuals with low IGF1 levels experienced substantial height improvements; the study also notes that growth discrepancies affect various body structures differently, including minor genital and mammary abnormalities.
View Article and Find Full Text PDF
Article Synopsis
  • - Meier-Gorlin syndrome (MGS) is a genetic disorder that mainly affects growth and development, marked by features like microtia (ear deformities), patellar aplasia/hypoplasia (underdeveloped knee caps), and short stature, with most cases linked to mutations in specific genes involved in cell-cycle regulation.
  • - A study of 45 individuals with MGS found that 35 had mutations in one of five key genes, with 82% showing the characteristic triad of symptoms, while additional features included mammary hypoplasia and genital abnormalities.
  • - Differences in genotype affect severity, with certain mutations leading to more severe outcomes, such as growth retardation; treatments like growth hormone and estrogen may
View Article and Find Full Text PDF

Meier-Gorlin syndrome (ear, patella and short-stature syndrome) is an autosomal recessive primordial dwarfism syndrome characterized by absent or hypoplastic patellae and markedly small ears¹⁻³. Both pre- and post-natal growth are impaired in this disorder, and although microcephaly is often evident, intellect is usually normal in this syndrome. We report here that individuals with this disorder show marked locus heterogeneity, and we identify mutations in five separate genes: ORC1, ORC4, ORC6, CDT1 and CDC6.

View Article and Find Full Text PDF

A 32-year follow-up of the first patient reported with the Floating-Harbor syndrome is discussed. He has been in good overall health. His facial appearance, a hallmark of this syndrome, had remained fairly characteristic except for some changes secondary to age.

View Article and Find Full Text PDF

Juvenile hyaline fibromatosis (JHF) and infantile systemic hyalinosis (ISH) are autosomal recessive conditions characterized by multiple subcutaneous skin nodules, gingival hypertrophy, joint contractures, and hyaline deposition. We previously mapped the gene for JHF to chromosome 4q21. We now report the identification of 15 different mutations in the gene encoding capillary morphogenesis protein 2 (CMG2) in 17 families with JHF or ISH.

View Article and Find Full Text PDF